AV Fistula Surgery — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

An arteriovenous (AV) fistula is a surgically created direct connection between an artery and a vein, most commonly the radial artery and cephalic vein in the forearm (radiocephalic fistula). This connection causes arterial blood pressure to dilate and thicken the vein wall over 6–12 weeks — a process called maturation — creating a vessel robust enough to tolerate repeated needle puncture three times per week for haemodialysis. The AV fistula is the gold standard vascular access for haemodialysis, preferred over synthetic AV grafts and central venous catheters due to superior longevity and lower infection and thrombosis rates. The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend AV fistula creation at least 6 months before the anticipated start of dialysis. An arteriovenous (AV) fistula is a surgically created direct connection between an artery and a vein, most commonly the radial artery and cephalic vein in the forearm (radiocephalic fistula). This connection causes arterialised blood flow into the venous system, causing the vein to dilate, thicken, and develop arterial-calibre blood flow over 6–12 weeks — a process called maturation. The matured fistula provides the high-volume vascular access (blood flow 350–500 mL/min) required for haemodialysis. The Kidney Disease Outcomes Quality Initiative (KDOQI) and European guidelines designate the AV fistula as the preferred form of long-term dialysis access due to superior longevity, lowest infection risk, and lowest cardiovascular event rate compared to tunnelled catheters and synthetic grafts. AV fistula surgery is performed by vascular surgeons or specialist renal access surgeons.

AV fistula surgery is indicated for patients with end-stage renal disease (ESRD) with GFR below 15 mL/min/1.73m² who are planning to start haemodialysis, and for patients with rapidly progressive chronic kidney disease (CKD) Stage 4–5 in whom dialysis is anticipated within 12 months. Pre-operative vein mapping with duplex ultrasound is mandatory to identify suitable forearm or upper arm veins (minimum 2.5 mm diameter) and confirm arterial patency. The radiocephalic (Brescia-Cimino) fistula at the wrist is the first-line choice; brachiobasilic or brachiocephalic fistulas in the upper arm are alternatives when forearm veins are inadequate. AV fistula surgery is indicated for patients with end-stage renal disease (ESRD) with GFR below 15 mL/min/1.73m² who are planning to start haemodialysis, and for patients with rapidly progressive chronic kidney disease expected to reach dialysis within 6–12 months, to allow adequate maturation time. Pre-operative vein mapping with duplex ultrasound identifies suitable vessels — a minimum cephalic vein diameter of 2.5 mm (ideally 3 mm or more) and radial artery diameter of 1.6 mm are required for a successful radiocephalic fistula. Patients with veins unsuitable for radiocephalic fistula are considered for brachiocephalic fistula (brachial artery to cephalic vein at the elbow). Patients with poor veins, expected short life expectancy, or bridging need may receive a synthetic AV graft instead. Diabetes, obesity, and prior failed fistulas increase the technical challenge.

Under local or regional (axillary block) anaesthesia, the surgeon makes a longitudinal or transverse incision over the wrist or antecubital fossa. The radial artery and cephalic vein are dissected and mobilised. An end-of-vein to side-of-artery anastomosis is the most common configuration, using 6/0 or 7/0 polypropylene sutures under loupe magnification or operating microscope. Blood flow through the anastomosis is confirmed by a palpable thrill and auscultation for a bruit. The wound is closed in layers. The procedure takes 1–2 hours. Some centres perform ultrasound-guided vein distension mapping and pre-operative vessel preparation with nitropaste to optimise maturation. Under local or regional (axillary block) anaesthesia, the surgeon makes a longitudinal or transverse incision over the wrist or antecubital fossa, depending on the planned fistula site. The radial artery and cephalic vein are carefully dissected and mobilised. A side-to-end (vein-to-artery) or end-to-side anastomosis is fashioned using interrupted or continuous 7-0 or 8-0 monofilament sutures under loupe magnification or a surgical microscope. On completion, the clamps are released and a thrill (vibratory sensation) and bruit (audible vascular murmur) are confirmed immediately, indicating patency. The wound is closed in layers and a light dressing applied. A Doppler flow check confirms adequate flow (target >500 mL/min at the anastomosis). The procedure takes 60–90 minutes. The arm is wrapped in a light bandage — not a tight bandage — and the patient is discharged the same day with instructions on fistula care and maturation monitoring.

AV fistulas provide the most durable and safest dialysis access. Well-matured fistulas achieve 3-year primary patency rates of 60–70% and can function for 10–20 years with proper care. Infection rates are 50–100 times lower than central venous catheters, reducing hospitalisation and bacteraemia risk. Blood flow through a mature fistula (350–500 mL/min) ensures optimal dialysis adequacy (Kt/V ≥1.4). The Brescia-Cimino fistula, first described in 1966, remains a surgical landmark that transformed renal replacement therapy. Patients with functioning AV fistulas have significantly better survival and quality of life than those dependent on catheters. AV fistulas provide the most durable and safest dialysis access available. Well-matured fistulas achieve 3-year primary patency rates of 60–70% and can function for 10–20 years with proper care. Infection rates are dramatically lower than tunnelled catheters (0.1 infections per 1,000 patient-days versus 3–8 for tunnelled catheters), translating into fewer hospitalisations and lower sepsis risk. Fistulas also carry a lower risk of central venous stenosis — a complication that can permanently compromise dialysis access sites. Patients with well-functioning fistulas have significantly better cardiovascular outcomes and lower all-cause mortality compared to those dialysing via catheter. The absence of prosthetic material removes the risk of synthetic graft infection (which requires surgical removal). Cost savings over 5 years compared to catheter-based dialysis are substantial — estimated at USD 15,000–20,000 per patient.

Primary failure to mature occurs in 20–30% of AV fistulas, particularly in elderly patients, diabetics, and women with smaller veins. Thrombosis of the fistula (clotting) can occur acutely or during long-term use and is salvaged by surgical thrombectomy or radiological intervention (balloon angioplasty). Steal syndrome — hand ischaemia from diversion of arterial flow to the low-resistance fistula — occurs in 1–5% and may require banding or revision. Aneurysm formation at the needle site, high-output cardiac failure (rare, with very large fistulas), and wound haematoma are additional risks. Regular surveillance (fistula flow, pressure monitoring) detects early stenosis and prevents thrombosis. Primary failure to mature occurs in 20–30% of AV fistulas, particularly in elderly patients, diabetics, and women with smaller veins. Thrombosis of the fistula (clotting) can occur acutely within the first 24 hours or late during long-term use, and is treated with surgical thrombectomy or radiological thrombolysis. Stenosis at the anastomosis or within the draining vein causes inadequate dialysis flow and requires balloon angioplasty. Steal syndrome — whereby the fistula diverts blood from the hand, causing coldness, pain, or ischaemic damage — occurs in 1–8% of cases and may require surgical banding or DRIL (distal revascularisation-interval ligation) procedure. High-output cardiac failure is a rare complication of high-flow fistulas in patients with pre-existing cardiac dysfunction. Aneurysmal dilatation of the fistula vein at needle insertion sites occurs over years of use and may require surgical repair if skin thinning creates rupture risk.

Most patients are discharged the same day. The fistula arm must be protected — no blood pressure cuffs, venepuncture, or tight clothing on the fistula arm. The arm should be elevated for 24–48 hours to reduce swelling. A palpable thrill and audible bruit are checked daily by the patient to confirm fistula patency. Squeezing a soft ball for 5 minutes several times daily encourages venous dilation and accelerates maturation. The fistula is assessed by a nephrologist or dialysis nurse at 4–6 weeks; adequate maturation (vein diameter ≥6 mm, depth <6 mm, flow >500 mL/min) must be confirmed before the first dialysis needle insertion at 6–12 weeks. Most patients are discharged the same day after AV fistula creation. The fistula arm must be carefully protected — no blood pressure cuffs, venepuncture, IV cannulas, or tight clothing on the fistula arm throughout its lifetime. The arm should be elevated for 24–48 hours to reduce swelling. Patients are taught to check the fistula thrill daily by placing two fingers gently over the anastomosis and feeling the continuous vibration; absence of thrill requires urgent medical review for possible thrombosis. The fistula is assessed for maturation by duplex ultrasound at 4–6 weeks. First cannulation is typically delayed for 6–8 weeks (or longer in poor maturers) to allow vessel wall strengthening. Progressive exercise of the fistula arm (squeezing a soft rubber ball) promotes vein maturation. Heavy lifting and compression of the fistula arm are permanently restricted during dialysis sessions.